MORDOR II: Persistence of Benefit of Azithromycin for Childhood Mortality

Background. MORDOR I found that 2 years of biannual mass azithromycin administration reduced post-neonatal childhood mortality by 18% in Niger. Over time, this benefit could increase with each distribution or wane due to antibiotic resistance. Here in MORDOR II, we treated communities in both arms f...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:N Engl J Med
मुख्य लेखकों: Keenan, Jeremy D., Arzika, Ahmed M., Maliki, Ramatou, Boubacar, Nameywa, Elh Adamou, Sanoussi, Moussa Ali, Maria, Cook, Catherine, Lebas, Elodie, Lin, Ying, Ray, Kathryn J., O’Brien, Kieran S., Doan, Thuy, Oldenburg, Catherine E., Callahan, E. Kelly, Emerson, Paul M., Porco, Travis C., Lietman, Thomas M.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Massachusetts Medical Society 2019
विषय:
Research Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512890/
https://ncbi.nlm.nih.gov/pubmed/31167050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1817213
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन